Medicament formulation with a controlled release of an active agent

US6270799A · kind A · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Hans-Martin Siefert · Berlin, DE
• Patrick Bosche · Odenthal, DE
• Heino Stass · Neunburg vorm Wald, DE
• Stefan Kettelhoit · Solingen, DE
• Tobias Laich · Cologne, DE

Key dates

• Filing date: Mar 17, 2000
• Grant date: Aug 7, 2001
• Expiry date: Mar 17, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to drug formulations which comprise 1-cyclopropyl-7-([S,S]-2,8-diazabicyclo[4.3. 0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as active compound which release the active compound they contain at a defined release rate.